ABBV:SWX
AbbVie Common Stock
CHF 169.00
0.00%
(0.00) 1D
Jun 3, 3:27:18 PM GMT+2 · CHF
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ABBV...
Mkt. cap
458.04B
Avg. vol.
0.00
Volume
0.00
52-wk high
CHF 185.19
52-wk low
CHF 161.58
Shares outstanding
1.00
No. of employees
57K
Mkt. cap
458.04B
Avg. vol.
0.00
Volume
0.00
52-wk high
CHF 185.19
52-wk low
CHF 161.58
Shares outstanding
1.00
No. of employees
57K
News stories
From web sources and news partners
GuruFocus
·
35 minutes ago
AbbVie's Rinvoq Shows Promise in Vitiligo Trials, ABBV Stock Hig
Seeking Alpha
·
1 hour ago
AbbVie long-term data buoys Rinvoq for vitiligo
Kalkine Media
·
2 hours ago
Why Is AbbVie (NYSE:ABBV) Suddenly a Must-Watch Healthcare Stocks Stock Today?
Investing.com Canada
·
2 hours ago
AbbVie reports long-term vitiligo data for RINVOQ at EADV By Investing.com
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorBiotechnology
Websiteabbvie.com